BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16399538)

  • 1. Hepatitis B vaccination in heart transplant candidates.
    Foster WQ; Murphy A; Vega DJ; Smith AL; Hott BJ; Book WM
    J Heart Lung Transplant; 2006 Jan; 25(1):106-9. PubMed ID: 16399538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies.
    Pinney SP; Cheema FH; Hammond K; Chen JM; Edwards NM; Mancini D
    J Heart Lung Transplant; 2005 Jan; 24(1):34-7. PubMed ID: 15653376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
    Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
    Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of maternal and fetal hepatitis B antibody titers following maternal vaccination in pregnancy.
    Ingardia CJ; Kelley L; Lerer T; Wax JR; Steinfeld JD
    Am J Perinatol; 1999; 16(3):129-32. PubMed ID: 10438194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
    Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou].
    Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B prophylaxis in hepatitis B-negative recipients transplanted with donor grafts positive for hepatitis B core antibodies.
    Scuderi V; Ceriello A; Santaniello W; Aragiusto G; Romano M; Migliaccio C; Calise F
    Transplant Proc; 2011; 43(1):271-3. PubMed ID: 21335203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
    Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.
    Sobhonslidsuk A; Sornmayura P; Sumethkul V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S257-61. PubMed ID: 17044481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.